A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2006
10/19/2006	DE102005017301A1 Substituierte Chromanderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted chroman derivatives, processes for their preparation and their use as anti-inflammatories
10/19/2006	DE102005016634A1 Neuartige Aza-Hetercyclen als Kinase-Inhibitoren Novel aza-heterocycles as kinase inhibitors
10/19/2006	CA2604640A1 Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/19/2006	CA2604443A1 Use of anti-ngf antibody for improving stiffness in osteoarthritis
10/19/2006	CA2604115A1 Spiro-oxindole compounds and their uses as therapeutic agents
10/19/2006	CA2604010A1 Spiroheterocyclic compounds and their uses as therapeutic agents
10/19/2006	CA2604007A1 Use of fril proteins for reducing the production of pro-inflammatory cytokines
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2602549A1 Anti-inflammatory modalities
10/19/2006	CA2598208A1 Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
10/19/2006	CA2598207A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
10/18/2006	EP1712566A1 Inflammatory cytokine inhibitor
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1711484A1 Synthesis of cyanoimino-benzoimidazoles
10/18/2006	EP1711475A1 2-(phenylamino)-pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders.
10/18/2006	EP1711459A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
10/18/2006	EP1711457A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
10/18/2006	EP1711197A1 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1339714B1 Novel sulfonamide-substituted pyrazolopyridine derivatives
10/18/2006	EP1337636B1 Soluble zcytor 11 cytokine receptors
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	EP1072266B8 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
10/18/2006	EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
10/18/2006	EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
10/18/2006	CN2827371Y External application traditional Chinese medicine bag for treating psychalgia
10/18/2006	CN1849306A Matrix metalloproteinase inhibitors
10/18/2006	CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases
10/18/2006	CN1849153A Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
10/18/2006	CN1849116A Carbamate compounds for use in the treatment of pain
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847236A 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847226A Quinolyl amide derivative and its prepn process and use
10/18/2006	CN1846782A Rheumatism treating medicine liquid for fire treatment in meridian sequence
10/18/2006	CN1846780A Anticancer analgetic Chinese medicine composition and its prepn process
10/18/2006	CN1846776A Injection of long-chain fat from zedoary oil and its prepn process
10/18/2006	CN1846770A Ointment for treating rheumatism, wound pain and swelling boil
10/18/2006	CN1846749A Groundcherry oral liquid and its prepn process
10/18/2006	CN1846744A Chinese medicine for treating acute and chronic appendicitis
10/18/2006	CN1846741A Superfine Chinese medicine powder prepn for treating rheumatism and its prepn
10/18/2006	CN1846719A Rheumatism treating medicine and its prepn process
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846696A Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/18/2006	CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/18/2006	CN1279963C Process for preparing product containing antiinflammatory, anticoagulant and antibacterial components from ginger and its product and medical composition
10/18/2006	CN1279958C Compound formula preparation eontaining glucocorticoid medicine
10/18/2006	CN1279957C Medicine for treating rheumatoid anthritis and its preparation method
10/18/2006	CN1279948C Medicine for treating arthritis and atrophic arthritis
10/18/2006	CN1279946C Medicinal wine and its producing method
10/18/2006	CN1279931C Medicine for treating primary and secondary headache
10/18/2006	CN1279895C Ground substance of plaster of Chinese traditional medicine and plaster for external application prepared from the substance
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122678 (Trans)-(3,4-Dimethyl-cyclopentyldine)-acetic acid ethyl ester; treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, irritable bowel syndrome (IBS), and inflammation
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122208 Administering aliquot of blood which has been treated ex vivo with stressors such as oxidation, thermal stress and electromagnetic radiation; wherein concentration of reactive oxygen species in neuronal cells or tissues is reduced
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/12/2006	WO2006107957A2 Device and methods for treating paranasal sinus conditions
10/12/2006	WO2006107941A1 DERIVATIVES OF [6,7-DIHYDRO-5HIMIDAZO [l,2-ALPHA] IMIDAZOLE-3-SULFONYL]-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS
10/12/2006	WO2006107923A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
10/12/2006	WO2006106959A1 Anti-cd-20 monoclonal antibody
10/12/2006	WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group
10/12/2006	WO2006106887A1 Edible composition containing component extracted from salix sp. extract
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	WO2006105945A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments
10/12/2006	WO2006105796A1 Novel indolinone derivatives
10/12/2006	WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis
10/12/2006	WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006	WO2006087147A3 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
10/12/2006	WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/12/2006	WO2005097113A3 5-ht2b receptor antagonists
10/12/2006	US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
10/12/2006	US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds

1 ... 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 ... 1272